Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Primary day in Iowa, Montana, New Jersey, New Mexico and South Dakota

What to watch in today’s primaries

It’s primary day in Iowa, Montana, New Jersey, New Mexico and South Dakota. Here’s what we’re tracking today:

Who will follow Rosendale? A crowded field is vying to replace Rep. Matt Rosendale (R-Mont.) in Montana’s ruby-red 2nd District. State Auditor Troy Downing is a leading contender in the Republican primary. A number of House conservatives, including Freedom Caucus Chair Bob Good (R-Va.), have endorsed the state’s Superintendent of Public Instruction Elsie Arntzen. Former Rep. Denny Rehberg (R-Mont.) is also running to return to Congress, along with retired DEA agent Stacy Zinn.

Will Iowa Republicans beat back their right-wing challengers? Rep. Randy Feenstra (R-Iowa) is the favorite to dispatch Kevin Virgil, a hardline conservative looking to oust the incumbent. Notably, Virgil is endorsed by former Rep. Steve King (R-Iowa). Feenstra beat King in a primary following public outrage over King’s racist comments. Former 2024 presidential candidate Vivek Ramaswamy is also backing Virgil.

Rep. Mariannette Miller-Meeks (R-Iowa) is also facing a longshot challenge from the right in the shape of David Pautsch.

Who will replace Kim? Rep. Andy Kim (D-N.J.) vacated the 3rd District to run for Senate, leaving two Democrats — Herb Conaway Jr. and Carol Murphy — as leading contenders to replace him. Conaway Jr., a state assembly member, is backed by 314 Action Fund and VoteVets. Murphy, also a state legislator, has the backing of EMILYs List.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.